Version 1
: Received: 6 December 2023 / Approved: 7 December 2023 / Online: 7 December 2023 (05:51:06 CET)
How to cite:
Fávaro, W.J.; Böckelmann, P.K.; Tizziani, S.H.; Duran, N. New Advances on Canine Bladder Cancer: Immunotherapy and Nanotechnology Applications. Preprints2023, 2023120473. https://doi.org/10.20944/preprints202312.0473.v1
Fávaro, W.J.; Böckelmann, P.K.; Tizziani, S.H.; Duran, N. New Advances on Canine Bladder Cancer: Immunotherapy and Nanotechnology Applications. Preprints 2023, 2023120473. https://doi.org/10.20944/preprints202312.0473.v1
Fávaro, W.J.; Böckelmann, P.K.; Tizziani, S.H.; Duran, N. New Advances on Canine Bladder Cancer: Immunotherapy and Nanotechnology Applications. Preprints2023, 2023120473. https://doi.org/10.20944/preprints202312.0473.v1
APA Style
Fávaro, W.J., Böckelmann, P.K., Tizziani, S.H., & Duran, N. (2023). <strong>New Advances on Canine Bladder Cancer: Immunotherapy and Nanotechnology Applications</strong>. Preprints. https://doi.org/10.20944/preprints202312.0473.v1
Chicago/Turabian Style
Fávaro, W.J., Silvia H.S. Tizziani and Nelson Duran. 2023 "<strong>New Advances on Canine Bladder Cancer: Immunotherapy and Nanotechnology Applications</strong>" Preprints. https://doi.org/10.20944/preprints202312.0473.v1
Abstract
Human urinary bladder cancer has similar development that invasive urothelial cancer that happens spontaneously in dogs. Then, research of these malignant tumors associated with the advances of new treatment drive to the specific fight of the urothelial tumor cell, is highly valuably related to efficiency and reduction of side effects of treatments, even extrapolating to humans. Thus, a review of the most important aspects on new advances on canine bladder cancer was achieved. Many forms of therapies are being reported; one of them, of highly promising feature is the treatment with immunomodulators. The resemblance between spontaneous urothelial cancer in canines and urinary bladder cancer in humans makes this canine tumor relevant animal model to research and advances of treatment that may be more efficient in management of tumor with less unfavorable effects. Immunomodulators exhibit important outcomes when used in the therapy of bladder cancer in dogs. Nanomaterials that are possible carriers of some kinds of drugs to the target tumor significantly raise the efficiently of the therapy. Therefore, the advancement of immunomodulator combined with nanoparticles can disrupt the therapy of bladder cancer in dogs and thereafter in humans.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
